ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1478

Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population

Ivan Ferraz-Amaro1, Robert Winchester2, Peter K. Gregersen3, Richard J. Reynolds4, Annette M. Oeser5, Cecilia P. Chung6, C. Michael Stein6, Mary Chester M. Wasko7, Jon T. Giles8 and Joan Bathon2, 1Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 2Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 3Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Med Res, Manhasset, NY, 4Medicine, University of Alabama at Birmingham, Birmingham, AL, 5Vanderbilt University Medical Center, Nashville, TN, 6Medicine, Vanderbilt University Medical Center, Nashville, TN, 7Lupus Center, Pittsburgh, PA, 8Rheumatology, Columbia University Medical Center, NY, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: coronary artery disease and rheumatoid arthritis (RA), Gene Expression

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In the general population individuals with coronary artery disease (CAD) have a significantly increased frequency of particular susceptibility single nucleotide polymorphisms (SNPs). Since CAD is increased in rheumatoid arthritis (RA), we sought to determine whether RA patients with CAD will have an increased frequency of these SNPs compared to those without CAD, implying that RA enhances the risk for CAD by acting on established genetic pathways predisposing to CAD, or alternatively, whether RA acts to increase CAD by mechanisms independent of these genetic pathways.

Methods: CAD was assessed by coronary artery calcification (CAC) using computed-tomography in 561 patients with RA. 100 SNPs associated with CAD in the general population were genotyped or imputed and their relation to CAC established through multiple regression analysis for individual SNPs and a genetic risk score (GRS) representing their cumulative effect.

Results: Ninety-one CAD SNPs were genotyped successfully; these were not significantly associated with CAC (Agatston units) or different CAC categorizations, either individually or collectively in the GRS. Only rs6544713 (ABCG8), rs3869109 (HCG27), rs1332844 (PHACTR1), rs579459 (ABO), rs4773144 (COL4A2), rs2075650 (TOMM40) and rs9982601 (KCNE2) expressed any positive relation with CAC in one or more of the analyses. Notably, none of the group of the 12 SNPs mapping in the 53 kb region of chromosome 9p21 that are among the strongest predictors of CAD in the general population exhibited any association with CAD. Moreover, rs1333040 (CDKN2B-AS1), which in the general population is positively associated with CAD risk, showed a significant inverse association between genotype and CAC. Only rs579459 (ABO) exhibited a consistent positive association between genotype and CAC score, with a significant increase of the effect allele frequency in both homozygous or heterozygous genotype distributions. When the association of the CAD related SNPS with CAC was studied through the non weighted and weighted set of SNPs, no significant association was found. In particular, an increase in the number of homozygous cardiovascular disease related SNPs was not significantly associated with an increase in logCAC Agatston units. GRS was not associated with CAC both in the univariate, and in the multivariate analysis adjusted for age and sex and for traditional cardiovascular factors. Additionally, when CAD related SNPs were weighted by their effect sizes, the resulting GRS was not significantly associated with CAC. Besides, trend analysis showed no relation between GRS and log CAC Agatson units (p=0.93). Interestingly, the positive association found between DAS28 and CAC after adjusting for traditional cardiovascular risk factors was not modified by correcting for the CAD related SNPs GRS.

Conclusion: The increased risk for CAC in RA does not appear to primarily operate through established genetically regulated atherogenic mechanisms that are preponderant in the general population.


Disclosure: I. Ferraz-Amaro, None; R. Winchester, None; P. K. Gregersen, None; R. J. Reynolds, None; A. M. Oeser, None; C. P. Chung, None; C. M. Stein, None; M. C. M. Wasko, None; J. T. Giles, None; J. Bathon, None.

To cite this abstract in AMA style:

Ferraz-Amaro I, Winchester R, Gregersen PK, Reynolds RJ, Oeser AM, Chung CP, Stein CM, Wasko MCM, Giles JT, Bathon J. Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/coronary-artery-calcification-in-rheumatoid-arthritis-patients-is-not-characterized-by-an-increase-in-genes-associated-with-coronary-artery-disease-in-the-general-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/coronary-artery-calcification-in-rheumatoid-arthritis-patients-is-not-characterized-by-an-increase-in-genes-associated-with-coronary-artery-disease-in-the-general-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology